Fatty Liver in Indian Men: Why It Is Showing Up at 28, Not 58

For most of the last century, "fatty liver" was something a doctor mentioned to a man in his late fifties who drank. That is not who is being diagnosed now. Hepatologists across Indian metros have spent the past two years reporting the same shift: the scans showing liver fat increasingly belong to men in their twenties and thirties, many of whom have never touched alcohol.

The data caught up in 2026. A nationwide study led by CSIR — the Phenome India cohort, published in The Lancet Regional Health – Southeast Asia in February 2026 — screened adults at 37 CSIR laboratories across 27 Indian cities. Of the 7,764 participants analysed, the age-adjusted prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) was 38.9%. Split by sex, it was 45.9% in men against 33% in women. Close to one in two Indian men in that cohort had fat in their liver, and almost none of them knew it.

What "fatty liver" actually means now

The condition has been renamed, and the new name explains the problem better than the old one. What used to be called non-alcoholic fatty liver disease (NAFLD) is now MASLD — metabolic dysfunction-associated steatotic liver disease. It means fat has accumulated in liver cells alongside at least one metabolic factor: a wide waist, raised blood sugar, high triglycerides, low HDL, or high blood pressure.

The rename mattered because "non-alcoholic" told people what the condition wasn't and nothing about what it was. Plenty of men heard "not alcohol" and concluded there was nothing to act on. The metabolic label points at the actual driver: this is the liver's share of the same problem that produces belly fat, prediabetes and rising triglycerides.

It also runs on a scale, which is the part that gets lost in a one-line ultrasound report:

• Simple steatosis — fat in the liver, no meaningful inflammation. Very common, and the stage where change is easiest.
• MASH (steatohepatitis) — fat plus inflammation and liver-cell injury. A smaller subset.
• Fibrosis — scarring from sustained inflammation, graded F1 to F4. This is the stage that actually predicts long-term liver outcomes.

In the same national cohort, significant fibrosis was found in 6.3% of people who had MASLD. That is the useful way to hold both facts at once: the condition is extremely common, and the serious end of it is not.

Why it is hitting men in their twenties and thirties

The most quoted Indian number on this comes from a study of IT employees in Hyderabad, published in Scientific Reports in 2025: of 345 employees aged 30 to 60 screened between 2023 and 2024, 290 — 84% — had liver steatosis. The same paper found roughly 72% sitting more than eight hours a day, about 70% sleeping under seven hours, and a significant association with sugar-sweetened beverages.

That is not a mysterious epidemic. It is a fairly ordinary description of a modern Indian desk job:

• Long uninterrupted sitting. Muscle that is never used stops pulling glucose out of the blood efficiently, and the liver picks up the surplus.
• Liquid sugar. Cold drinks, packaged juices, sweetened coffee and energy drinks deliver fructose in a form the liver converts to fat particularly readily. This is the single easiest thing on the list to change.
• Short and shifted sleep. Under-seven-hour nights and rotating shifts worsen insulin resistance independently of what you eat. Our sleep guide covers the practical side of fixing that.
• Refined carbohydrate-heavy meals with very little protein or fibre — the standard canteen and late-night-delivery pattern.
• Alcohol on top. Not the cause of MASLD, but it stacks additional injury onto a liver that already has fat in it.

None of these is dramatic on its own. That is exactly why a liver quietly accumulates fat for a decade while everything feels fine.

"But I'm thin"

This deserves its own section because it is where most Indian men wrongly rule themselves out.

Lean MASLD — liver fat in someone with a normal BMI — is disproportionately common in Indians. In one Indian biopsy-based study of lean liver donors, 33.7% had fatty liver despite a normal BMI. The underlying reason is body composition: at the same BMI, South Asians tend to carry more visceral fat around the organs and less muscle than European populations. The scale is a poor instrument for this, and a normal BMI hides a metabolically loaded abdomen surprisingly well.

The practical version: a 26-year-old with thin arms, a soft belly, a desk job and two cold drinks a day is a completely plausible candidate. Waist measurement is more informative than weight here, and it is the number a doctor will actually ask for.

The symptoms (there mostly aren't any)

Fatty liver is usually silent. It is most often found by accident — an abdominal ultrasound done for something else, or a routine corporate health check.

When anything is noticed, it is vague: persistent tiredness that sleep doesn't fix, or a dull heaviness under the right ribs. Both are so non-specific that they are useless for self-diagnosis. Jaundice, swelling in the abdomen or legs, and easy bruising are signs of advanced liver disease, not of an early fatty liver, and they need a doctor immediately rather than a search engine.

The takeaway is not to hunt for symptoms. It is that feeling perfectly fine is not evidence of anything either way.

How it is actually diagnosed

Three pieces, in a doctor's hands:

1. Ultrasound of the abdomen — the usual first look, and where "grade 1 / grade 2 fatty liver" comes from. It is a rough visual grading of how much fat is visible, not a measure of damage.
2. Blood work — liver enzymes ALT (SGPT) and AST (SGOT), plus the metabolic picture: fasting glucose or HbA1c, a lipid profile, and often thyroid. Important caveat: enzymes are frequently normal in people who have liver fat, so a clean liver function test does not rule it out.
3. A fibrosis assessment — either a score calculated from routine blood values and age, or elastography (FibroScan), which measures liver stiffness. This is the part that separates "common and manageable" from "needs specialist follow-up", and it is a doctor's call whether you need it.

If you are getting a baseline panel anyway, the sensible move is to include liver and metabolic markers rather than testing the liver in isolation — our guide to the blood tests every man should get by 30 covers what a reasonable panel looks like. Booking through MediBuddy or a similar platform with home collection makes the logistics easier, but a report without a doctor reading it is just a PDF. Consultation in India is now routine, quick and unremarkable — this is not a condition anyone will judge you for.

What actually works

Here the evidence is unusually clear, and unusually unglamorous.

Weight loss is the intervention with real evidence behind it, and it works in a dose-response way. Across the research, losing roughly 3-5% of body weight starts reducing liver fat; around 7% is where steatohepatitis tends to resolve; and about 10% is where fibrosis improvement shows up. For an 80 kg man that is a first target of roughly 3-4 kg — meaningfully less intimidating than the number most people assume. If your BMI is normal, the targets are proportionally smaller, and waist circumference is the better thing to track.

Exercise helps even when the scale doesn't move. Both aerobic work and resistance training reduce liver fat independently of weight loss, which matters if your weight is already "normal". Muscle is metabolically useful tissue; building some is not vanity here.

Cut liquid sugar first. Of every dietary change available, removing sweetened drinks is the highest-yield and easiest to sustain. Nothing else on the list gives that ratio.

Fix the sleep window. Chronically short sleep worsens insulin resistance, and no diet compensates for it.

Be honest about alcohol. Even moderate intake adds injury to a liver already carrying fat. If a doctor has flagged fibrosis, that conversation becomes more serious, not less.

Coffee shows a consistent association with better liver outcomes in observational studies. It is a reasonable thing to keep if you already drink it; it is not a strategy, and it is not a reason to start.

What does not work: detox drinks, cleanses, "liver tonics" and crash diets. There is no evidence any of them clear fat from the liver, and some herbal and ayurvedic liver preparations have been linked to liver injury in Indian case reports — the opposite of the intended effect. Tell your doctor about every supplement you take, including the ones bought as "natural". This is the same pattern we describe in testosterone myths: the strongest marketing tends to sit exactly where the evidence is weakest.

The new drug conversation

In July 2026, India's drug regulator CDSCO approved semaglutide 2.4 mg (Wegovy) for adults with non-cirrhotic MASH who have moderate to advanced liver fibrosis, to be used alongside a reduced-calorie diet and increased physical activity. It is the first GLP-1 medicine cleared in India for a liver indication, and it was widely covered — which is why it now comes up in every conversation about fatty liver.

Worth being precise about what that approval covers. It is for a diagnosed, advanced subset of patients with confirmed fibrosis, identified by a specialist. It is not an approval for the grade-1 fatty liver noted in passing on a routine ultrasound, and the approval itself specifies diet and activity alongside the drug rather than instead of it. It is prescription-only, injectable, expensive, and carries real side effects.

If a doctor who has seen your reports raises it, that is a legitimate discussion. Sourcing a prescription drug on your own because a headline made it sound like a shortcut is not, and this is one of the areas where self-medication in India causes genuine harm.

The bottom line

Fatty liver in Indian men is now common enough that assuming you don't have it is a coin flip at best. It is also mostly silent, frequently invisible on liver enzymes alone, and entirely capable of showing up in someone who is thin and doesn't drink.

The response is not panic, and it is not a tonic. It is a doctor-ordered look — an ultrasound plus a metabolic panel — and, if fat is found, the boring dose-response fix that the research actually supports: lose a modest amount of abdominal weight, move more, drop the sweetened drinks, sleep properly. Caught early, this is one of the more forgiving things a routine scan can turn up. Ignored for a decade because nothing hurt, it is considerably less so.